Tags

Type your tag names separated by a space and hit enter

Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.
Clin Microbiol Infect. 2007 Dec; 13(12):1141-3.CM

Abstract

Shigellosis is a major cause of diarrhoea-related morbidity and mortality, especially in developing countries. Effective antibiotic treatment reduces the average duration of illness by reducing faecal excretion of the bacterium and preventing further transmission and potentially lethal complications. Treatment of shigellosis is currently limited by the high prevalence of multidrug-resistant strains of Shigella. Although fluoroquinolones are currently effective in treating adults, resistance to fluoroquinolones among Shigella spp. is emerging, and their use in children is subject to limitations. Azithromycin and third-generation cephalosporins are also effective in the treatment of shigellosis, but monitoring of Shigella isolates to detect the emergence of resistance is essential.

Authors

No affiliation info available

Pub Type(s)

Editorial

Language

eng

PubMed ID

17953700

Citation

Niyogi, S K.. "Increasing Antimicrobial Resistance--an Emerging Problem in the Treatment of Shigellosis." Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 13, no. 12, 2007, pp. 1141-3.
Niyogi SK. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis. Clin Microbiol Infect. 2007;13(12):1141-3.
Niyogi, S. K. (2007). Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 13(12), 1141-3.
Niyogi SK. Increasing Antimicrobial Resistance--an Emerging Problem in the Treatment of Shigellosis. Clin Microbiol Infect. 2007;13(12):1141-3. PubMed PMID: 17953700.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis. A1 - Niyogi,S K, Y1 - 2007/10/22/ PY - 2007/10/24/pubmed PY - 2008/1/18/medline PY - 2007/10/24/entrez SP - 1141 EP - 3 JF - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases JO - Clin Microbiol Infect VL - 13 IS - 12 N2 - Shigellosis is a major cause of diarrhoea-related morbidity and mortality, especially in developing countries. Effective antibiotic treatment reduces the average duration of illness by reducing faecal excretion of the bacterium and preventing further transmission and potentially lethal complications. Treatment of shigellosis is currently limited by the high prevalence of multidrug-resistant strains of Shigella. Although fluoroquinolones are currently effective in treating adults, resistance to fluoroquinolones among Shigella spp. is emerging, and their use in children is subject to limitations. Azithromycin and third-generation cephalosporins are also effective in the treatment of shigellosis, but monitoring of Shigella isolates to detect the emergence of resistance is essential. SN - 1198-743X UR - https://www.unboundmedicine.com/medline/citation/17953700/Increasing_antimicrobial_resistance__an_emerging_problem_in_the_treatment_of_shigellosis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1198-743X(14)62580-5 DB - PRIME DP - Unbound Medicine ER -